Hemiplegic migraine associated with etonogestrel 68 mg implant insertion case report

IF 2.8 2区医学 Q1 OBSTETRICS & GYNECOLOGY

Contraception Pub Date : 2024-12-14 DOI:10.1016/j.contraception.2024.110783

Hallie N. Nelson, Rebekah Sugarman, Melissa L. Wong

引用次数: 0

Abstract

We present a case of suspected induced intractable headaches and paralysis after receiving an etonogestrel 68 mg implant. After extensive neurological evaluation, the etonogestrel implant was removed and neurological symptoms resolved.

The case raises concerns about a potential rare risk of progestin-containing contraceptives in patients with migraines with aura warranting further investigation.

查看原文本刊更多论文

与依托孕烯 68 毫克植入物相关的偏瘫性偏头痛病例报告。

我们提出一个病例，怀疑诱发顽固性头痛和瘫痪后，接受依托诺孕酮68毫克植入物。经过广泛的神经学评估后，移除依替诺孕酮植入物，神经学症状得到缓解。该病例引起了人们对偏头痛先兆患者使用含孕激素避孕药的潜在罕见风险的关注，值得进一步调查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Contraception 医学-妇产科学

CiteScore

4.70

自引率

17.20%

发文量

211

审稿时长

69 days

期刊介绍： Contraception has an open access mirror journal Contraception: X, sharing the same aims and scope, editorial team, submission system and rigorous peer review. The journal Contraception wishes to advance reproductive health through the rapid publication of the best and most interesting new scholarship regarding contraception and related fields such as abortion. The journal welcomes manuscripts from investigators working in the laboratory, clinical and social sciences, as well as public health and health professions education.